<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27659" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Preterm and Term Prelabor Rupture of Membranes (PPROM and PROM)</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Dayal</surname>
            <given-names>Shailja</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jenkins</surname>
            <given-names>Suzanne M.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hong</surname>
            <given-names>Peter L.</given-names>
          </name>
          <aff>Nassau University Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shailja Dayal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Suzanne Jenkins declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Peter Hong declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27659.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Prelabor rupture of membranes (PROM) occurs when the fetal membranes rupture before the onset of labor contractions. This condition can lead to spontaneous labor or, if labor does not begin, increase the risk of complications such as intraamniotic infection and placental abruption, particularly at term. When PROM occurs before 37 weeks gestation, it is classified as preterm PROM (PPROM), posing unique challenges in managing the risk of prematurity alongside potential complications for the mother and child. PROM can arise from various causes, including membrane weakening, intraamniotic pressure, infection, and other stressors&#x02014;with risk factors like a history of PROM, short cervical length, and certain lifestyle factors. Management depends largely on gestational age, with delivery often recommended after 37 weeks and more conservative approaches taken for PPROM to balance fetal development with the risk of infection.</p>
        <p>This activity for healthcare professionals enhances participants' competence in identifying PROM and PPROM risk factors, accurately assessing clinical presentations, and utilizing the latest evaluation and management protocols. Learners gain insights into implementing strategies considering gestational age and maternal-fetal health, such as corticosteroid administration, antibiotics, and expectant management in PPROM cases to reduce neonatal risks. Additionally, the course emphasizes the importance of interprofessional collaboration with obstetricians, neonatologists, and nurses to deliver comprehensive care, thus optimizing outcomes for mothers and neonates.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Assess gestational age and fetal lung maturity to determine the safest course of action regarding delivery or expectant management.</p></list-item><list-item><p>Apply current guidelines for monitoring fetal well-being and signs of infection during conservative management of prelabor rupture of membranes.</p></list-item><list-item><p>Select appropriate timing for delivery based on maternal and fetal status, balancing risks and benefits to minimize complications.</p></list-item><list-item><p>Apply interprofessional team strategies to improve care coordination and outcomes&#x000a0;in patients with prelabor rupture of membranes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27659&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27659">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27659.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Prelabor rupture of membranes (PROM) is defined as the rupture of the fetal membranes before the onset of labor contractions. When PROM occurs before 37 weeks gestation, the term preterm PROM (PPROM) is used.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref> Spontaneous labor often follows the rupture of membranes (ROM). At term, a delay in the onset of labor following ROM increases&#x000a0;the risk of obstetric complications such as intraamniotic infection and placental abruption. PPROM is a complicated condition where clinicians must balance the risks of prolonging pregnancy with fetal risks of prematurity.</p>
        <p>Management of PPROM in the previable and periviable periods can be especially complicated, depending&#x000a0;on gestational age, with immediate delivery often recommended after 37 weeks. However, in cases of PPROM, expectant management, corticosteroids, antibiotics, and sometimes tocolytics may be used to extend pregnancy when possible to reduce neonatal risks. Understanding the latest recommendations and the evidence supporting them is essential for clinicians and patients to make informed decisions regarding their care and optimize maternal and fetal outcomes.</p>
      </sec>
      <sec id="article-27659.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>
<bold>Pathophysiology of Premature Rupture of Membranes</bold>
</p>
        <p>The fetal membranes play a critical role during gestation, providing mechanical and immunologic protection for the developing fetus. The fetal membranes are made up of 2 layers: the amnion, which is the inner layer, and the chorion, which is the outer membrane connected to the decidual layer of the endometrium. Therefore, the amnion responds to changes within the amniotic cavity, while the chorion plays an important role in immune tolerance at the maternal-fetal interface.<xref ref-type="bibr" rid="article-27659.r2">[2]</xref>&#x000a0;The amnion and chorion are connected by the twelfth week of gestation by a strong yet flexible extra-cellular matrix comprised of various collagen types, providing the membranes' structural framework.<xref ref-type="bibr" rid="article-27659.r2">[2]</xref><xref ref-type="bibr" rid="article-27659.r3">[3]</xref>&#x000a0;At the end of gestation, significant membrane remodeling occurs due to programmed activation of matrix metalloproteinases and selective apoptosis, leading to significant weakening of the membranes.<xref ref-type="bibr" rid="article-27659.r4">[4]</xref>&#x000a0;Interestingly, tumor necrosis factor &#x003b1; or interleukin 1&#x003b2; induces the same biochemical markers of membrane weakening and apoptosis seen at the end of gestation.<xref ref-type="bibr" rid="article-27659.r4">[4]</xref></p>
        <p>
<bold>Etiology&#x000a0;of Premature Rupture of Membranes</bold>
</p>
        <p>PROM or PPROM may occur for various reasons, including normal physiologic weakening of the membranes at term, increased intraamniotic pressure,&#x000a0;intraamniotic infection or inflammation, oxidative stress, and membrane remodeling capacity abnormalities.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r2">[2]</xref><xref ref-type="bibr" rid="article-27659.r5">[5]</xref>&#x000a0;Inflammation can activate proteases that degrade collagen within the fetal membranes, weakening and predisposing them to rupture. Intrauterine infection is also a common cause of inflammation. However, while&#x000a0;intraamniotic infection is seen in a significant proportion&#x000a0;of patients with PPROM, it may be either a cause or a result of membrane weakening. For example, while an ascending genital infection from bacterial vaginosis can certainly cause an innate inflammatory response, sterile inflammation from bleeding or tobacco use may also weaken the fetal membranes, allowing for microbial invasion.<xref ref-type="bibr" rid="article-27659.r2">[2]</xref><xref ref-type="bibr" rid="article-27659.r6">[6]</xref></p>
        <p>Oxidative stress generates reactive oxygen species, which can target and degrade collagen. Reactive oxygen species are most commonly produced during cellular respiration and when they are released by immune cells during phagocytosis. Typically, these reactive oxygen species are balanced by antioxidants. However, the reactive oxygen species and antioxidants can become imbalanced due to dietary deficiencies of antioxidants, tobacco use, and high fetoplacental energy demands, including those seen in pregnancies at high altitudes or with concordant intrinsic microvascular disease.<xref ref-type="bibr" rid="article-27659.r2">[2]</xref>&#x000a0;Additionally, evidence demonstrates that some single-nucleotide polymorphisms involved in the metabolism of the extracellular matrix can significantly affect the risk of PPROM.<xref ref-type="bibr" rid="article-27659.r7">[7]</xref>&#x000a0;However, despite various underlying etiologies, no apparent cause is often identified in patients presenting with PROM and PPROM.</p>
        <p>
<bold>Risk Factors&#x000a0;of Premature Rupture of Membranes</bold>
</p>
        <p>Risk factors for PPROM include:</p>
        <list list-type="bullet">
          <list-item>
            <p>A history of PPROM</p>
          </list-item>
          <list-item>
            <p>Short cervical length</p>
          </list-item>
          <list-item>
            <p>Second- or third-trimester vaginal bleeding</p>
          </list-item>
          <list-item>
            <p>Amniocentesis and other antenatal intrauterine procedures</p>
          </list-item>
          <list-item>
            <p>Uterine overdistension</p>
          </list-item>
          <list-item>
            <p>Connective tissue disorders</p>
          </list-item>
          <list-item>
            <p>Congenital uterine anomalies</p>
          </list-item>
          <list-item>
            <p>Nutritional deficiencies of copper and ascorbic acid</p>
          </list-item>
          <list-item>
            <p>Low body mass index</p>
          </list-item>
          <list-item>
            <p>Low socioeconomic status</p>
          </list-item>
          <list-item>
            <p>Cigarette smoking and recreational drug use&#x000a0;<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r5">[5]</xref><xref ref-type="bibr" rid="article-27659.r6">[6]</xref><xref ref-type="bibr" rid="article-27659.r8">[8]</xref><xref ref-type="bibr" rid="article-27659.r9">[9]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27659.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>PROM complicates approximately 8% of term pregnancies. After PROM at term, spontaneous labor begins within 24 hours in 60% to 70% of patients and within 72 hours in over 95%.<xref ref-type="bibr" rid="article-27659.r10">[10]</xref> In the TERMPROM study, a large prospective randomized controlled trial comparing expectant management to immediate induction of labor, the median time to delivery in the expectant management group was approximately 33 hours.<xref ref-type="bibr" rid="article-27659.r10">[10]</xref>&#x000a0;Preterm PROM is less common, complicating only about 1% of deliveries overall. Previable and periviable PPROM occurring before 24 weeks gestation occurs in 0.3% to 0.4% of pregnancies.<xref ref-type="bibr" rid="article-27659.r11">[11]</xref>&#x000a0;Black women are twice as likely than White women to experience PPROM and are more than 6 times as likely to experience recurrent PPROM.<xref ref-type="bibr" rid="article-27659.r12">[12]</xref></p>
      </sec>
      <sec id="article-27659.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical History</bold>
</p>
        <p>Patients with ruptured membranes will&#x000a0;classically present with vaginal fluid leakage. Leakage may be significant and continuous or much lighter and intermittent. Some patients may describe their symptoms as an increase in watery discharge. By definition, patients with PROM or PPROM are not in active labor, so regular uterine contractions are absent before membrane rupture.</p>
        <p>When obtaining the clinical history, clinicians should inquire about contractions that may indicate the onset of labor, vaginal bleeding (may suggest placental abruption), and fetal movement to assess fetal well-being. Furthermore, additional details regarding ROM should be obtained, including the onset of suspected membrane rupture as prolonged ROM increases risks, the volume of fluid loss observed, and the color and odor of the fluid, which can suggest the presence of meconium or intraamniotic infection. Associated features, including pain, recent sexual encounters, recent trauma, and recent physical activity, are also vital to a thorough history.</p>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>A sterile speculum exam should be performed to assess the fluid. Direct observation of fluid leakage from the cervical os confirms ROM. Pooling, which refers to the rapid collection of amniotic fluid in the lower blade of the speculum, may also be seen. If leakage of amniotic fluid from the os is not seen, gentle fundal pressure can be applied, or the patient can be asked to Valsalva or cough to provoke fluid leakage. The color and odor of the fluid should be noted. A fluid sample can also be obtained for further evaluation if the diagnosis is in question.&#x000a0;</p>
        <p>During the speculum exam, dilation and effacement of the cervix should be visually assessed. Digital examinations increase the risk of intraamniotic infection in patients with ROM; digital&#x000a0;examinations to assess cervical dilation, effacement, and station should be avoided unless delivery appears imminent or the patient appears to be in active labor.<xref ref-type="bibr" rid="article-27659.r13">[13]</xref><xref ref-type="bibr" rid="article-27659.r14">[14]</xref><xref ref-type="bibr" rid="article-27659.r15">[15]</xref>&#x000a0;Patients should also be inspected for any signs of cervicitis, vaginitis, vaginal bleeding, and umbilical cord or fetal prolapse. One of the most significant potential complications of PROM and PPROM is intrauterine infection. Therefore, all patients presenting with PROM should be assessed for signs and symptoms of intrauterine infection, which include maternal fever, fetal tachycardia, such as a fetal heart rate 160 bpm or more for at least 10 minutes, uterine tenderness, and purulent or foul-smelling discharge.<xref ref-type="bibr" rid="article-27659.r16">[16]</xref><xref ref-type="bibr" rid="article-27659.r17">[17]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27659.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Confirming the Diagnosis of Rupture of Membranes</bold>
</p>
        <p>Direct visualization of fluid leakage from the cervical os or gross pooling confirms the diagnosis. However, if the diagnosis is still in question after a sterile speculum examination, additional testing can help confirm the diagnosis.</p>
        <p>
<bold>Microscopy</bold>
</p>
        <p>A sample of amniotic fluid can be smeared directly on a slide and allowed to dry. When examined microscopically, dried amniotic fluid forms a crystalized pattern that appears like branches of a fern tree; this is known as arborization or ferning and confirms ROM. Of note, cervical mucus can also produce a crystallized pattern.&#x000a0;However, cervical mucus forms&#x000a0;fern-like patterns in thick linear bands secondary to its stringlike macroscopic structure (Spinnbarkeit). This crystallized pattern is visually distinct from amniotic fluid, which tends to form a thinner, more delicate pattern across the entire smear.</p>
        <p>
<bold>Vaginal fluid pH testing</bold>
</p>
        <p>A pH test can be performed on vaginal fluid. The pH of amniotic fluid is typically slightly basic, with a range of 7 to 7.4, while normal vaginal secretions in pregnancy have a pH between 3.8 and 4.<xref ref-type="bibr" rid="article-27659.r18">[18]</xref><xref ref-type="bibr" rid="article-27659.r19">[19]</xref> False-positive pH tests, however, are common, as multiple other causes of abnormally high vaginal pH may be present, including the presence of blood or semen, alkaline antiseptics, and bacterial vaginosis. Additionally, false-negative results may occur with prolonged rupture of membranes or minimal amounts of leakage. For these reasons, pH testing is reasonable to include as part of the evaluation for ROM, but it does not definitively confirm or exclude the diagnosis.&#x000a0;</p>
        <p>
<bold>Diagnostic tests for amniotic fluid proteins</bold>
</p>
        <p>Several commercially available tests can&#x000a0;detect the presence of amniotic fluid proteins within a sample. The proteins detected in some of the most commonly&#x000a0;used tests are placental alpha microglobulin-1 and insulin-like growth factor binding protein-1 (IGFBP-1). One test assesses for the combination of IGFBP-1 and alpha-fetoprotein. The sensitivity of these tests in diagnosing ROM ranges from about 95% to 99% compared to around 85% for conventional methods.<xref ref-type="bibr" rid="article-27659.r20">[20]</xref><xref ref-type="bibr" rid="article-27659.r21">[21]</xref><xref ref-type="bibr" rid="article-27659.r22">[22]</xref></p>
        <p>
<bold>Dye test</bold>
</p>
        <p>If the diagnosis remains unclear after the initial evaluation, a dye test, often called a "tampon test," can be considered. However, these tests are invasive and rarely used in modern practice. To perform the test, a tampon is placed in the vagina, and dye is injected via a transabdominal needle under ultrasound guidance into the amniotic cavity.&#x000a0;ROM is confirmed if the dye appears on the tampon removed 20 minutes later. Indigo carmine was traditionally used for this test but is no longer readily available; fluorescein and phenol-sulfonphthalein are reasonable alternatives.<xref ref-type="bibr" rid="article-27659.r23">[23]</xref></p>
        <p>
<bold>Additional Diagnostic Studies</bold>
</p>
        <p>Other evaluation studies that may also be conducted to assess maternal-fetal well-being or further narrow the underlying etiology include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Evaluation of fetal well-being</bold>:&#x000a0;Membrane rupture can cause fetal distress, so fetal well-being should always be confirmed. This is typically accomplished with cardiotocographic monitoring and a biophysical profile.<xref ref-type="bibr" rid="article-27659.r15">[15]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Obstetric ultrasound</bold>:&#x000a0;An obstetric ultrasound is recommended to assess the amniotic fluid volume, as oligohydramnios is often seen. The fetal presentation should also be confirmed, as spontaneous labor frequently follows ROM.&#x000a0;</p>
          </list-item>
          <list-item>
            <p><bold>Urinalysis</bold>: Urinary tract infections predispose patients to urinary incontinence episodes. If the diagnosis of ROM is in doubt, a urine sample can be obtained to rule out urinary tract infections.</p>
          </list-item>
          <list-item>
            <p><bold>Serum labs</bold>:&#x000a0;A maternal white blood cell count &#x0003e;15,000/mm<sup>3</sup> in the absence of corticosteroid administration is consistent with infection. However, in the absence of clinical findings suggesting intraamniotic infection (eg, fever, uterine tenderness, foul-smelling discharge, fetal tachycardia), an elevated white blood count is nonspecific.</p>
          </list-item>
        </list>
        <p>
<bold>Group B Streptococcus Status</bold>
</p>
        <p>Management of PROM differs depending on the group B streptococcus (GBS) status. After 37 weeks gestation, GBS prophylaxis is only indicated in GBS-positive or other high-risk individuals. In preterm patients, a rectovaginal GBS culture should be obtained if one has not already been obtained in the previous 5 weeks.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r15">[15]</xref><xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r24">[24]</xref>&#x000a0;However, a GBS culture is not indicated if the pregnant individual already has an indication for intrapartum GBS prophylaxis, such as GBS-positive bacteriuria earlier in the pregnancy or a history of a prior neonate with invasive GBS disease.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r24">[24]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-27659.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Management of prelabor rupture of membrane cases is determined by gestational age at the time of membrane rupture (see <bold>Table.</bold> Summary of Management for Patients with Ruptured Membranes Based on Gestational Age). Gestational age guides the decision regarding immediate delivery versus expectant management and the need for corticosteroids with or without proephylactic tocolytics, latency antibiotics, GBS prophylaxis, and magnesium sulfate for neuroprotection. However, regardless of gestational age, immediate delivery is indicated for signs of nonreassuring fetal status, intraamniotic infection, placental abruption, and prolapsed umbilical cord.&#x000a0;</p>
        <table-wrap id="article-27659.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Summary of Management for Patients with Ruptured Membranes Based on Gestational Age</title>
          </caption>
          <table style="width: 555px; height: 464px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 83.5083px;" rowspan="1" colspan="1">
<bold>Gestational Age</bold>
</td>
                <td style="width: 93.25px;" rowspan="1" colspan="1">
<bold>Delivery</bold>
</td>
                <td style="width: 89.4167px;" rowspan="1" colspan="1">
<bold>GBS Prophylaxis</bold>
</td>
                <td style="width: 78.5167px;" rowspan="1" colspan="1">
<bold>Latency Antibiotics</bold>
</td>
                <td style="width: 150.708px;" rowspan="1" colspan="1">
<bold>Other Management</bold>
</td>
              </tr>
              <tr>
                <td style="width: 83.5083px;" rowspan="1" colspan="1">
<bold>&#x02265;37 weeks</bold>
</td>
                <td style="width: 93.25px;" rowspan="1" colspan="1">Delivery versus expectant management* for up to 24 hrs</td>
                <td style="width: 89.4167px;" rowspan="1" colspan="1">Yes, if positive or other indications** are present</td>
                <td style="width: 78.5167px;" rowspan="1" colspan="1">None</td>
                <td style="width: 150.708px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Treat&#x000a0;intraamniotic infection if present</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 83.5083px;" rowspan="1" colspan="1">
<p><bold>34 to 36 6/7 weeks</bold></p>
</td>
                <td style="width: 93.25px;" rowspan="1" colspan="1">Delivery versus expectant management</td>
                <td style="width: 89.4167px;" rowspan="1" colspan="1">Yes, unless there is a negative culture within the past 5 weeks</td>
                <td style="width: 78.5167px;" rowspan="1" colspan="1">None</td>
                <td style="width: 150.708px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Corticosteroids</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 83.5083px;" rowspan="1" colspan="1">
<bold>24 to 33 6/7 weeks</bold>
</td>
                <td style="width: 93.25px;" rowspan="1" colspan="1">Expectant management</td>
                <td style="width: 89.4167px;" rowspan="1" colspan="1">Yes, unless there is a negative culture within the past 5 weeks of gestation</td>
                <td style="width: 78.5167px;" rowspan="1" colspan="1">Indicated</td>
                <td style="width: 150.708px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Corticosteroids</p></list-item><list-item><p>Magnesium sulfate for neuroprotectin if &#x0003c;32 weeks gestation</p></list-item><list-item><p>+/- Tocolysis for up to 48 hours</p></list-item></list>
</td>
              </tr>
              <tr>
                <td style="width: 83.5083px;" rowspan="1" colspan="1">
<bold>Periviable and Previable</bold>
</td>
                <td style="width: 93.25px;" rowspan="1" colspan="1">Offer abortion care versus expectant management</td>
                <td style="width: 89.4167px;" rowspan="1" colspan="1">Consider at 23 weeks gestation</td>
                <td style="width: 78.5167px;" rowspan="1" colspan="1">Consider after 20 weeks gestation</td>
                <td style="width: 150.708px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Patient counseling</p></list-item><list-item><p>Corticosteroids, magnesium sulfate, and tocolysis can be considered&#x000a0;if neonatal resuscitation is planned&#x000a0;</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>GBS: group B&#x000a0;<italic toggle="yes">Streptococcus</italic></p>
        <p>*Only if GBS is negative.</p>
        <p>**Other indications include previous neonate with GBS disease; GBS bacteriuria at any time during the current pregnancy; GBS unknown with at least 1 of the following risk factors: ROM for 18 or more hours, the intrapartum temperature of 38.0 &#x000b0;C (100.4 &#x000b0;F) or higher, GBS positive in a prior pregnancy.<xref ref-type="bibr" rid="article-27659.r24">[24]</xref></p>
        <p>
<bold>Management Approach in Early Term and Term Patients (37 0/7 Weeks Gestation and Greater)</bold>
</p>
        <p>Immediately moving toward delivery after a diagnosis of PROM at term is associated with better maternal and fetal outcomes compared to expectant management.<xref ref-type="bibr" rid="article-27659.r25">[25]</xref>&#x000a0;For example, the TERMPROM trial, which compared expectant management with immediate induction of labor (IOL), showed that despite similar rates of cesarean birth and neonatal infection between the 2 groups, immediate IOL was associated with lower rates of maternal infection.<xref ref-type="bibr" rid="article-27659.r10">[10]</xref>&#x000a0;American, British, and Australian/New Zealander guidelines all generally concur and recommend initiating&#x000a0;IOL or performing a cesarean delivery if indicated immediately in patients who are GBS-positive or within 24 hours of PROM if GBS-negative or unknown.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r15">[15]</xref>&#x000a0;GBS prophylaxis should be administered as indicated.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r15">[15]</xref></p>
        <p>Multiple studies have examined&#x000a0;different methods of labor induction in patients with PROM. Notably, evidence suggests that intracervical catheters&#x000a0;should be avoided in patients with ruptured membranes, as they have been shown to nearly double the risk of&#x000a0;intraamniotic infection compared with pharmacologic induction methods.<xref ref-type="bibr" rid="article-27659.r26">[26]</xref><xref ref-type="bibr" rid="article-27659.r27">[27]</xref>&#x000a0;While oxytocin can be used alone for IOL in patients with PROM at term, there is no convincing evidence to support or avoid the use of prostaglandins for cervical ripening in this population. A Cochrane review from 2000 found that there appears to be an increased risk of intraamniotic infection with prostaglandins compared with oxytocin alone.<xref ref-type="bibr" rid="article-27659.r28">[28]</xref>&#x000a0;However, a&#x000a0;2005 meta-analysis showed that misoprostol was comparable to oxytocin as initial management for&#x000a0;IOL, with similar rates of vaginal birth within 12 and 24 hours and adverse maternal and neonatal outcomes.<xref ref-type="bibr" rid="article-27659.r29">[29]</xref>&#x000a0;Additionally, results from several small studies have shown a modest benefit to cervical ripening with prostaglandins in patients with term PROM and an unfavorable cervix.<xref ref-type="bibr" rid="article-27659.r30">[30]</xref>&#x000a0;At this time, the choice of whether to use a prostaglandin or oxytocin for cervical ripening in patients with&#x000a0;term PROM and an unfavorable cervix can be individualized and based on clinical factors in concert with clinician and patient preference.</p>
        <p>
<bold>Management Approach in Preterm Patients (36 6/7 or Fewer Weeks Gestation)</bold>
</p>
        <p>Management varies slightly between patients with PPROM before and after the 34-week gestation threshold. However, a single course of corticosteroids is recommended for all pregnant patients with PPROM between&#x000a0;viability&#x000a0;and 36 6/7 weeks gestation if delivery is anticipated before 37 weeks.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref>&#x000a0;Antenatal corticosteroids after PPROM have been shown to reduce neonatal mortality, respiratory distress syndrome, necrotizing enterocolitis, and intraventricular hemorrhage.<xref ref-type="bibr" rid="article-27659.r31">[31]</xref><xref ref-type="bibr" rid="article-27659.r32">[32]</xref><xref ref-type="bibr" rid="article-27659.r33">[33]</xref><xref ref-type="bibr" rid="article-27659.r34">[34]</xref>&#x000a0;</p>
        <p>
<bold>Late preterm (34 0/7 to 36 6/7 weeks gestation)</bold>
</p>
        <p>Immediate delivery is indicated if the patient is GBS-positive. However, if the patient is GBS negative or unknown, expectant management may be considered until 37 weeks. Study results have shown that immediate delivery is associated with higher rates of neonatal respiratory distress (8% versus 5%) and longer stays in intensive care (4 days versus 2 days). Expectant management is associated with lower rates of cesarean birth but increased rates of&#x000a0;intraamniotic infection and antepartum hemorrhage.<xref ref-type="bibr" rid="article-27659.r35">[35]</xref><xref ref-type="bibr" rid="article-27659.r36">[36]</xref>&#x000a0;Given these mixed results, thorough counseling, individualized care, and shared decision-making are recommended.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r15">[15]</xref> Corticosteroids are recommended, but latency antibiotics and tocolytics are not. Patients who are GBS unknown should be screened for GBS with a rectovaginal swab and started on GBS prophylaxis, which can be discontinued if the culture returns negative.<xref ref-type="bibr" rid="article-27659.r24">[24]</xref></p>
        <p>Generally, patients with preterm PROM undergoing expectant management should be admitted to the hospital with periodic assessments for fetal well-being, preterm labor, infection, placental abruption, and umbilical cord prolapse. Fetal well-being is typically monitored with regular cardiotocographic monitoring or biophysical profiles and serial growth ultrasounds. Maternal vital signs should be checked regularly, and a rise in temperature should raise suspicion of intraamniotic infection. However, in the absence of clinical signs of infection, monitoring leukocyte counts and inflammatory markers is not indicated; while leukocytosis and elevated inflammatory markers are often seen with intraamniotic infection, these findings are nonspecific and have not been shown to help diagnose&#x000a0;intraamniotic infection in the absence of other clinical signs or symptoms.<xref ref-type="bibr" rid="article-27659.r16">[16]</xref>&#x000a0;Additionally, corticosteroids will cause transient leukocytosis, making this finding difficult to interpret.</p>
        <p>
<bold>Early preterm (24 0/7 to 33 6/7 weeks gestation)</bold>
</p>
        <p>Expectant management is recommended when no maternal or fetal contraindications exist. Latency antibiotics, a single course of corticosteroids, and GBS prophylaxis&#x000a0;(unless known to be GBS-negative) are also all recommended.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r15">[15]</xref><xref ref-type="bibr" rid="article-27659.r24">[24]</xref>&#x000a0;To reduce the risk of cerebral palsy, intrapartum magnesium sulfate is recommended between viability and 31 6/7 weeks gestation according to American guidelines and between 24 and 29 6/7 weeks gestation according to British guidelines.<xref ref-type="bibr" rid="article-27659.r37">[37]</xref><xref ref-type="bibr" rid="article-27659.r38">[38]</xref>&#x000a0;Like patients in the late preterm with PPROM, patients in the early preterm period are usually monitored in the hospital and regularly assessed for signs of nonreassuring fetal well-being, preterm labor, and infection.</p>
        <p>Latency antibiotics have been shown to prolong pregnancy in patients with PPROM, reduce maternal and neonatal infections, and reduce fetal morbidity. A 7-day&#x000a0;course of therapy is recommended in patients with PPROM before 34&#x000a0;weeks gestation. The recommended regimen is intravenous ampicillin 2 g every 6 hours and erythromycin 250 mg every 6 hours for 48 hours, followed by oral amoxicillin 250 mg every 8 hours and erythromycin base 333 mg every 8 hours for 5 additional days.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r39">[39]</xref>&#x000a0;Azithromycin can be used as an alternative to erythromycin.<xref ref-type="bibr" rid="article-27659.r40">[40]</xref> Amoxicillin-clavulanic acid is not recommended due to increased rates of necrotizing enterocolitis.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r41">[41]</xref>&#x000a0;If the patient is a candidate for GBS prophylaxis, she should receive a regimen that covers GBS.<xref ref-type="bibr" rid="article-27659.r42">[42]</xref></p>
        <p>The use of tocolytics in patients with preterm PROM is controversial but can be considered for up to 48 hours in patients before 34 weeks gestation to allow the fetus to reap the full benefits of a corticosteroid course.<xref ref-type="bibr" rid="article-27659.r1">[1]</xref>&#x000a0;Prophylactic tocolytics may be associated with an extended latency period and a lower delivery risk within 48 hours. However, tocolytics are also associated with a higher risk of intrauterine infection&#x000a0;before 34 weeks. No significant maternal or neonatal benefit has been shown with tocolytics beyond benefits attributed to a complete course of corticosteroids.<xref ref-type="bibr" rid="article-27659.r43">[43]</xref>&#x000a0;</p>
        <p>
<bold>Previable and periviable (&#x0003c;24 weeks of gestation)</bold>
</p>
        <p>The periviable period is defined as the time between 20 and 25 6/7 weeks gestation.<xref ref-type="bibr" rid="article-27659.r44">[44]</xref>&#x000a0;The American Society for Maternal-Fetal Medicine recommends thorough, individualized counseling about the maternal and fetal risks associated with the patient's situation and offering patients with previable and periviable&#x000a0;PPROM abortion care.<xref ref-type="bibr" rid="article-27659.r45">[45]</xref>&#x000a0;Expectant management can be considered in the absence of contraindications to ongoing pregnancy, which includes intraamniotic infection, placental abruption, cord prolapse, and nonreassuring fetal status.&#x000a0;</p>
        <p>Significant maternal risks of expectant management include potentially severe infection, hemorrhage, and death. Results from a 2022 retrospective cohort of patients with PPROM between 14 and 24 weeks gestation by Sklar et al showed composite maternal morbidity rates of 60% in the expectant management group compared with only 33% in the abortion care group (see <bold>Table</bold>.&#x000a0;Maternal Morbidity After Preterm Premature Rupture of Membranes at &#x0003c;24 Weeks' Gestation).<xref ref-type="bibr" rid="article-27659.r11">[11]</xref>&#x000a0;</p>
        <table-wrap id="article-27659.table1" position="float" orientation="portrait">
          <caption>
            <title>Table. Maternal Morbidity After Preterm Premature Rupture of Membranes at &#x0003c;24 Weeks' Gestation&#x000a0;</title>
          </caption>
          <table style="width: 556px; height: 215px;" border="1" cellspacing="1" cellpadding="5">
            <tbody>
              <tr>
                <td style="width: 130.775px;" rowspan="1" colspan="1">&#x000a0;</td>
                <td style="width: 184.8px;" rowspan="1" colspan="1">
<bold>Expectant management</bold>
</td>
                <td style="width: 204.025px;" rowspan="1" colspan="1">
<bold>Termination of pregnancy (Induction of labor vs dilatation and evacuation)</bold>
</td>
              </tr>
              <tr>
                <td style="width: 130.775px;" rowspan="1" colspan="1">
<bold>Intraamniotic infection</bold>
</td>
                <td style="width: 184.8px;" rowspan="1" colspan="1">38.0%</td>
                <td style="width: 204.025px;" rowspan="1" colspan="1">13.0%</td>
              </tr>
              <tr>
                <td style="width: 130.775px;" rowspan="1" colspan="1">
<bold>Postpartum hemorrhage</bold>
</td>
                <td style="width: 184.8px;" rowspan="1" colspan="1">23.1%</td>
                <td style="width: 204.025px;" rowspan="1" colspan="1">11.0%</td>
              </tr>
              <tr>
                <td style="width: 130.775px;" rowspan="1" colspan="1">
<bold>Intensive care unit admission</bold>
</td>
                <td style="width: 184.8px;" rowspan="1" colspan="1">2.8%</td>
                <td style="width: 204.025px;" rowspan="1" colspan="1">0%</td>
              </tr>
              <tr>
                <td style="width: 130.775px;" rowspan="1" colspan="1">
<bold>Unplanned hysterectomy</bold>
</td>
                <td style="width: 184.8px;" rowspan="1" colspan="1">0.9%</td>
                <td style="width: 204.025px;" rowspan="1" colspan="1">0%</td>
              </tr>
              <tr>
                <td style="width: 130.775px;" rowspan="1" colspan="1">
<bold>Cesarean birth</bold>
</td>
                <td style="width: 184.8px;" rowspan="1" colspan="1">36.2% (of this group, 56.4% had a non-low transverse uterine incision)</td>
                <td style="width: 204.025px;" rowspan="1" colspan="1">N/A</td>
              </tr>
              <tr>
                <td style="width: 130.775px;" rowspan="1" colspan="1">
<bold>Composite morbidity</bold>
</td>
                <td style="width: 184.8px;" rowspan="1" colspan="1">60.2%</td>
                <td style="width: 204.025px;" rowspan="1" colspan="1">33.0%</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Clinicians should note that maternal sepsis can progress rapidly to death. For example, a study on maternal mortality in France provided results that found the median interval from PPROM to the first signs of infection was 5 days; the median time from infection diagnosis to death was only 18 hours.<xref ref-type="bibr" rid="article-27659.r46">[46]</xref>&#x000a0;A delay in uterine evacuation was determined to have contributed to at least some of the deaths in that series.&#x000a0;</p>
        <p>Notably, expectant management in&#x000a0;previable and periviable situations&#x000a0;is generally not associated with positive neonatal outcomes. In a European series of patients known as the PPROMEXIL-III cohort, 52 of 86 (60%) patients with previable PROM were delivered before 24 weeks, and only&#x000a0;23 neonates survived until discharge. Long-term data showed that 13 of these children (15% of the original 86) had normal neurodevelopment at 2 and 5 years.<xref ref-type="bibr" rid="article-27659.r47">[47]</xref>&#x000a0;This is similar to the results reported by Sklar et al, who found only 15.7% of women in the expectant management group avoided morbidity and had a neonate who survived until discharge.<xref ref-type="bibr" rid="article-27659.r11">[11]</xref></p>
        <p>Given these risks, the decision to proceed with abortion care versus expectant management should consider the ability of the&#x000a0;clinicians to care for the pregnant person and their neonate, the fetal prognosis, the "views of risk"&#x000a0;as determined by both the healthcare team and the patient, and patient preference.<xref ref-type="bibr" rid="article-27659.r45">[45]</xref>&#x000a0;In patients who chose abortion care, dilation and evacuation are associated with substantially lower risks of hemorrhage, infection, and retained tissue than induction of labor.<xref ref-type="bibr" rid="article-27659.r48">[48]</xref>&#x000a0;In patients who undergo expectant management, latency antibiotics can be considered as early as 20 0/7 weeks gestation, while&#x000a0;GBS prophylaxis, corticosteroids, tocolysis, and magnesium sulfate&#x000a0;are&#x000a0;not recommended until the time when neonatal resuscitation would be considered, which is typically between 22 and 24 weeks gestation, depending on local resources.<xref ref-type="bibr" rid="article-27659.r45">[45]</xref></p>
      </sec>
      <sec id="article-27659.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of fluid leaking from the vagina includes:</p>
        <list list-type="bullet">
          <list-item>
            <p>Vaginitis</p>
          </list-item>
          <list-item>
            <p>Lower urinary tract infection</p>
          </list-item>
          <list-item>
            <p>Urinary incontinence</p>
          </list-item>
          <list-item>
            <p>Fluids from recent intercourse</p>
          </list-item>
          <list-item>
            <p>Vesicovaginal fistula</p>
          </list-item>
          <list-item>
            <p>Trauma to the urogenital tract</p>
          </list-item>
        </list>
        <p>These alternative diagnoses can be ruled out with a proper history, physical examination, and basic diagnostic tests, such as a urinalysis and microscopic evaluation of vaginal secretions using potassium hydroxide and wet mount preparations.</p>
      </sec>
      <sec id="article-27659.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis is largely dependent on the gestational age at which membrane rupture occurs. After PROM at term, outcomes are generally favorable. Birth within 7 days of membrane rupture occurs in at least 50% of patients with PPROM. Although rare, cessation of fluid leakage with restoration of normal amniotic fluid volume and favorable outcomes is possible.<xref ref-type="bibr" rid="article-27659.r49">[49]</xref><xref ref-type="bibr" rid="article-27659.r50">[50]</xref><xref ref-type="bibr" rid="article-27659.r51">[51]</xref>&#x000a0;The risk of complications in PPROM is relatively high. As the latency period lengthens, the risk of maternal infection increases, but neonatal complications associated with extreme prematurity decrease.</p>
        <p>Regarding periviable PPROM, neonatal survival rates are much higher when PPROM occurs after 22 weeks (58%) than&#x000a0;when PPROM occurs before 22 weeks gestation (14% to 22%).<xref ref-type="bibr" rid="article-27659.r52">[52]</xref><xref ref-type="bibr" rid="article-27659.r53">[53]</xref> In a European series of patients known as the PPROMEXIL-III cohort, 52 of 86 (60%) patients&#x000a0;with previable PROM delivered before 24 weeks gestation, and only&#x000a0;23 neonates survived until discharge. Long-term data showed that 13 of these children (15% of the original 86) had normal neurodevelopment at 2 and 5 years.<xref ref-type="bibr" rid="article-27659.r47">[47]</xref>&#x000a0;Women with a history of PPROM have a higher risk of recurrent PPROM and preterm birth. Progesterone supplementation should be offered in future pregnancies to reduce the risk of spontaneous preterm birth.<xref ref-type="bibr" rid="article-27659.r54">[54]</xref></p>
      </sec>
      <sec id="article-27659.s10" sec-type="Complications">
        <title>Complications</title>
        <p>
<bold>Maternal Risks</bold>
</p>
        <p>Maternal complications associated with PROM&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intrauterine infection</p>
          </list-item>
          <list-item>
            <p>Sepsis</p>
          </list-item>
          <list-item>
            <p>Placental abruption</p>
          </list-item>
          <list-item>
            <p>Antenatal, intrapartum, and postpartum hemorrhage</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
        <p>
<bold>Fetal and Neonatal Risks</bold>
</p>
        <p>Fetal and neonatal complications associated with PROM include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Neonatal sepsis</p>
          </list-item>
          <list-item>
            <p>Complications of prematurity
<list list-type="bullet"><list-item><p>Respiratory distress syndrome</p></list-item><list-item><p>Intraventricular hemorrhage</p></list-item><list-item><p>Necrotizing enterocolitis</p></list-item><list-item><p>Retinopathy of prematurity</p></list-item><list-item><p>Hypothermia</p></list-item><list-item><p>Glucose and electrolyte abnormalities</p></list-item><list-item><p>Failure to thrive</p></list-item><list-item><p>Death</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Complications of prolonged oligohydramnios
<list list-type="bullet"><list-item><p>Pulmonary hypoplasia</p></list-item><list-item><p>Limb contractures and skeletal deformities&#x000a0;<xref ref-type="bibr" rid="article-27659.r1">[1]</xref><xref ref-type="bibr" rid="article-27659.r52">[52]</xref></p></list-item></list>
</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27659.s11" sec-type="Consultations">
        <title>Consultations</title>
        <p>Coordination between obstetric and pediatric services is essential to optimize neonatal care, especially in patients who deliver preterm, have prolonged rupture of membranes, and have other obstetric complications, eg, intraamniotic infection or placental abruption. Patients who experience PPROM can benefit from meeting with neonatal clinicians before delivery to understand the prognosis of their child. In the previable or periviable periods, these conversations can help patients choose whether they want to pursue abortion care or expectant management.</p>
      </sec>
      <sec id="article-27659.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should be instructed to present for evaluation if they ever experience leakage of fluid during pregnancy, as PPROM or PROM must always be ruled in these situations due to the increasing risk of complications associated with a delayed diagnosis.</p>
      </sec>
      <sec id="article-27659.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PROM requires immediate and coordinated action among a diverse healthcare team to ensure optimal patient-centered care and outcomes. Accurate diagnosis and gestational age assessment are pivotal, and while obstetricians or midwives typically manage PROM, care coordination is crucial. Nurses play a vital role in monitoring patients for signs of infection, placental abruption, or fetal distress, ensuring timely interventions when necessary. Pharmacists contribute by ensuring appropriate medication management, such as antibiotics and corticosteroids. Pediatric and anesthesiology teams must be kept informed of all preterm cases and ready to provide neonatal or obstetric support. Effective interprofessional communication ensures safety, enhances team performance, and improves maternal and fetal outcomes.</p>
      </sec>
      <sec id="article-27659.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27659&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27659">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/womens-health/premature-rupture-of-membranes/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27659">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27659/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27659">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27659.s15">
        <title>References</title>
        <ref id="article-27659.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siegler</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Solt</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>ACOG Practice Bulletin No. 217: Prelabor Rupture of Membranes.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>136</volume>
            <issue>5</issue>
            <fpage>1061</fpage>
            <pub-id pub-id-type="pmid">33093409</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Menon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Richardson</surname>
                <given-names>LS</given-names>
              </name>
            </person-group>
            <article-title>Preterm prelabor rupture of the membranes: A disease of the fetal membranes.</article-title>
            <source>Semin Perinatol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>41</volume>
            <issue>7</issue>
            <fpage>409</fpage>
            <page-range>409-419</page-range>
            <pub-id pub-id-type="pmid">28807394</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mossman</surname>
                <given-names>HW</given-names>
              </name>
            </person-group>
            <article-title>Classics revisited: Comparative morphogenesis of the fetal membranes and accessory uterine structures.</article-title>
            <source>Placenta</source>
            <year>1991</year>
            <season>Jan-Feb</season>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-5</page-range>
            <pub-id pub-id-type="pmid">2034592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moore</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Redline</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>The physiology of fetal membrane rupture: insight gained from the determination of physical properties.</article-title>
            <source>Placenta</source>
            <year>2006</year>
            <season>Nov-Dec</season>
            <volume>27</volume>
            <issue>11-12</issue>
            <fpage>1037</fpage>
            <page-range>1037-51</page-range>
            <pub-id pub-id-type="pmid">16516962</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouvier</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Forest</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Blanchon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bujold</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pereira</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gallot</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sapin</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gigu&#x000e8;re</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Risk Factors and Outcomes of Preterm Premature Rupture of Membranes in a Cohort of 6968 Pregnant Women Prospectively Recruited.</article-title>
            <source>J Clin Med</source>
            <year>2019</year>
            <month>Nov</month>
            <day>15</day>
            <volume>8</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">31731659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goldenberg</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Culhane</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Iams</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and causes of preterm birth.</article-title>
            <source>Lancet</source>
            <year>2008</year>
            <month>Jan</month>
            <day>05</day>
            <volume>371</volume>
            <issue>9606</issue>
            <fpage>75</fpage>
            <page-range>75-84</page-range>
            <pub-id pub-id-type="pmid">18177778</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Romero</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Friel</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Velez Edwards</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Kusanovic</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Hassan</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Mazaki-Tovi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vaisbuch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Erez</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Chaiworapongsa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>BD</given-names>
              </name>
              <name>
                <surname>Bartlett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Salisbury</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Anant</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Vovis</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Gomez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Behnke</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Oyarzun</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tromp</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM).</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2010</year>
            <month>Oct</month>
            <volume>203</volume>
            <issue>4</issue>
            <fpage>361.e1</fpage>
            <page-range>361.e1-361.e30</page-range>
            <pub-id pub-id-type="pmid">20673868</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mercer</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Goldenberg</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Meis</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Moawad</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Shellhaas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Caritis</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Thurnau</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Dombrowski</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Miodovnik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>McNellis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The Preterm Prediction Study: prediction of preterm premature rupture of membranes through clinical findings and ancillary testing. The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>183</volume>
            <issue>3</issue>
            <fpage>738</fpage>
            <page-range>738-45</page-range>
            <pub-id pub-id-type="pmid">10992202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Panagiotopoulos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tseke</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Michala</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Obstetric Complications in Women With Congenital Uterine Anomalies According to the 2013 European Society of Human Reproduction and Embryology and the European Society for Gynaecological Endoscopy Classification: A Systematic Review and Meta-analysis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2022</year>
            <month>Jan</month>
            <day>01</day>
            <volume>139</volume>
            <issue>1</issue>
            <fpage>138</fpage>
            <page-range>138-148</page-range>
            <pub-id pub-id-type="pmid">34856567</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hannah</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Ohlsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farine</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hewson</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Hodnett</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Myhr</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Weston</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Willan</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Induction of labor compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group.</article-title>
            <source>N Engl J Med</source>
            <year>1996</year>
            <month>Apr</month>
            <day>18</day>
            <volume>334</volume>
            <issue>16</issue>
            <fpage>1005</fpage>
            <page-range>1005-10</page-range>
            <pub-id pub-id-type="pmid">8598837</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sklar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sheeder</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Teal</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Maternal morbidity after preterm premature rupture of membranes at &#x0003c;24 weeks' gestation.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>226</volume>
            <issue>4</issue>
            <fpage>558.e1</fpage>
            <page-range>558.e1-558.e11</page-range>
            <pub-id pub-id-type="pmid">34736914</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>DeFranco</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Stamilio</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Muglia</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>A population-based study of race-specific risk for preterm premature rupture of membranes.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>199</volume>
            <issue>4</issue>
            <fpage>373.e1</fpage>
            <page-range>373.e1-7</page-range>
            <pub-id pub-id-type="pmid">18667175</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexander</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Miodovnik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Thurnau</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Goldenberg</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Meis</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Moawad</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Iams</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Vandorsten</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Dombrowski</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>McNellis</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The impact of digital cervical examination on expectantly managed preterm rupture of membranes.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>183</volume>
            <issue>4</issue>
            <fpage>1003</fpage>
            <page-range>1003-7</page-range>
            <pub-id pub-id-type="pmid">11035354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seaward</surname>
                <given-names>PG</given-names>
              </name>
              <name>
                <surname>Hannah</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Myhr</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Farine</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ohlsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Haque</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Weston</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hewson</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ohel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hodnett</surname>
                <given-names>ED</given-names>
              </name>
            </person-group>
            <article-title>International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1997</year>
            <month>Nov</month>
            <volume>177</volume>
            <issue>5</issue>
            <fpage>1024</fpage>
            <page-range>1024-9</page-range>
            <pub-id pub-id-type="pmid">9396886</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ronzoni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boucoiran</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Yudin</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Coolen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pylypjuk</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Melamed</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Holden</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Guideline No. 430: Diagnosis and management of preterm prelabour rupture of membranes.</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>44</volume>
            <issue>11</issue>
            <fpage>1193</fpage>
            <page-range>1193-1208.e1</page-range>
            <pub-id pub-id-type="pmid">36410937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Saade</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Polin</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Grobman</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Buhimschi</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Silver</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Raju</surname>
                <given-names>TNK</given-names>
              </name>
              <collab>Chorioamnionitis Workshop Participants</collab>
            </person-group>
            <article-title>Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>127</volume>
            <issue>3</issue>
            <fpage>426</fpage>
            <page-range>426-436</page-range>
            <pub-id pub-id-type="pmid">26855098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <article-title>Committee Opinion No. 712: Intrapartum Management of Intraamniotic Infection.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e95</fpage>
            <page-range>e95-e101</page-range>
            <pub-id pub-id-type="pmid">28742677</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Y&#x00131;lmaz Semerci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Y&#x000fc;cel</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Erbas</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Gunkaya</surname>
                <given-names>OS</given-names>
              </name>
              <name>
                <surname>Talmac</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>&#x000c7;etinkaya</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The utility of amniotic fluid pH and electrolytes for prediction of neonatal respiratory disorders.</article-title>
            <source>J Matern Fetal Neonatal Med</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>2</issue>
            <fpage>253</fpage>
            <page-range>253-257</page-range>
            <pub-id pub-id-type="pmid">30033781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Riedewald</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kreutzmann</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Heinze</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saling</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Vaginal and cervical pH in normal pregnancy and pregnancy complicated by preterm labor.</article-title>
            <source>J Perinat Med</source>
            <year>1990</year>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>181</fpage>
            <page-range>181-6</page-range>
            <pub-id pub-id-type="pmid">2384841</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cousins</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Smok</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Lovett</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Poeltler</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>AmniSure placental alpha microglobulin-1 rapid immunoassay versus standard diagnostic methods for detection of rupture of membranes.</article-title>
            <source>Am J Perinatol</source>
            <year>2005</year>
            <month>Aug</month>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>317</fpage>
            <page-range>317-20</page-range>
            <pub-id pub-id-type="pmid">16118720</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lee</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Norwitz</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Jun</surname>
                <given-names>JK</given-names>
              </name>
            </person-group>
            <article-title>Measurement of placental alpha-microglobulin-1 in cervicovaginal discharge to diagnose rupture of membranes.</article-title>
            <source>Obstet Gynecol</source>
            <year>2007</year>
            <month>Mar</month>
            <volume>109</volume>
            <issue>3</issue>
            <fpage>634</fpage>
            <page-range>634-40</page-range>
            <pub-id pub-id-type="pmid">17329514</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomasino</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Levi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Draper</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neubert</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Diagnosing rupture of membranes using combination monoclonal/polyclonal immunologic protein detection.</article-title>
            <source>J Reprod Med</source>
            <year>2013</year>
            <season>May-Jun</season>
            <volume>58</volume>
            <issue>5-6</issue>
            <fpage>187</fpage>
            <page-range>187-94</page-range>
            <pub-id pub-id-type="pmid">23763001</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ireland</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Rodriguez</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Acosta</surname>
                <given-names>OM</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Intra-amniotic Dye Alternatives for the Diagnosis of Preterm Prelabor Rupture of Membranes.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>129</volume>
            <issue>6</issue>
            <fpage>1040</fpage>
            <page-range>1040-1045</page-range>
            <pub-id pub-id-type="pmid">28486367</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <article-title>Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>135</volume>
            <issue>2</issue>
            <fpage>e51</fpage>
            <page-range>e51-e72</page-range>
            <pub-id pub-id-type="pmid">31977795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellussi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Seidenari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Juckett</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Di Mascio</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Berghella</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Induction within or after 12 hours of &#x02265;36 weeks' prelabor rupture of membranes: a systematic review and meta-analysis.</article-title>
            <source>Am J Obstet Gynecol MFM</source>
            <year>2021</year>
            <month>Sep</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>100425</fpage>
            <pub-id pub-id-type="pmid">34153513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mackeen</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Quinn</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Movva</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Berghella</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ananth</surname>
                <given-names>CV</given-names>
              </name>
            </person-group>
            <article-title>Intracervical balloon catheter for labor induction after rupture of membranes: a systematic review and meta-analysis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>224</volume>
            <issue>6</issue>
            <fpage>624</fpage>
            <page-range>624-628</page-range>
            <pub-id pub-id-type="pmid">33689751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <article-title>Foley Plus Oxytocin Compared With Oxytocin for Induction After Membrane Rupture: A Randomized Controlled Trial: Correction.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>131</volume>
            <issue>4</issue>
            <fpage>745</fpage>
            <pub-id pub-id-type="pmid">29578977</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tan</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Hannah</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Prostaglandins versus oxytocin for prelabour rupture of membranes at term.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2000</year>
            <volume>1997</volume>
            <issue>2</issue>
            <fpage>CD000159</fpage>
            <pub-id pub-id-type="pmid">10796161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Nuthalapaty</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Carver</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Case</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ramsey</surname>
                <given-names>PS</given-names>
              </name>
            </person-group>
            <article-title>Misoprostol for labor induction in women with term premature rupture of membranes: a meta-analysis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>106</volume>
            <issue>3</issue>
            <fpage>593</fpage>
            <page-range>593-601</page-range>
            <pub-id pub-id-type="pmid">16135593</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>G&#x000fc;ng&#x000f6;rd&#x000fc;k</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Asicioglu</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Besimoglu</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>G&#x000fc;ng&#x000f6;rd&#x000fc;k</surname>
                <given-names>OC</given-names>
              </name>
              <name>
                <surname>Yildirm</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ark</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sahbaz</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Labor induction in term premature rupture of membranes: comparison between oxytocin and dinoprostone followed 6 hours later by oxytocin.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>206</volume>
            <issue>1</issue>
            <fpage>60.e1</fpage>
            <page-range>60.e1-8</page-range>
            <pub-id pub-id-type="pmid">21924396</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <collab>Committee on Obstetric Practice</collab>
            <article-title>Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation.</article-title>
            <source>Obstet Gynecol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>130</volume>
            <issue>2</issue>
            <fpage>e102</fpage>
            <page-range>e102-e109</page-range>
            <pub-id pub-id-type="pmid">28742678</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dalziel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2006</year>
            <month>Jul</month>
            <day>19</day>
            <issue>3</issue>
            <fpage>CD004454</fpage>
            <pub-id pub-id-type="pmid">16856047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carlo</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>McDonald</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Fanaroff</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Vohr</surname>
                <given-names>BR</given-names>
              </name>
              <name>
                <surname>Stoll</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Ehrenkranz</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bell</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Laptook</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Shankaran</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Poindexter</surname>
                <given-names>BB</given-names>
              </name>
              <name>
                <surname>Hale</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Schibler</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Van Meurs</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Watterberg</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Faix</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Frantz</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Higgins</surname>
                <given-names>RD</given-names>
              </name>
              <collab>Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network</collab>
            </person-group>
            <article-title>Association of antenatal corticosteroids with mortality and neurodevelopmental outcomes among infants born at 22 to 25 weeks' gestation.</article-title>
            <source>JAMA</source>
            <year>2011</year>
            <month>Dec</month>
            <day>07</day>
            <volume>306</volume>
            <issue>21</issue>
            <fpage>2348</fpage>
            <page-range>2348-58</page-range>
            <pub-id pub-id-type="pmid">22147379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Natarajan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rane</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cortez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lua</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of extremely low birth weight infants with varying doses and intervals of antenatal steroid exposure.</article-title>
            <source>J Perinat Med</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>419</fpage>
            <page-range>419-23</page-range>
            <pub-id pub-id-type="pmid">20297898</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morris</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Roberts</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Bowen</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Bond</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Algert</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Thornton</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Crowther</surname>
                <given-names>CA</given-names>
              </name>
              <collab>PPROMT Collaboration</collab>
            </person-group>
            <article-title>Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Jan</month>
            <day>30</day>
            <volume>387</volume>
            <issue>10017</issue>
            <fpage>444</fpage>
            <page-range>444-52</page-range>
            <pub-id pub-id-type="pmid">26564381</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quist-Nelson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Ruigh</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Seidler</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>van der Ham</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Willekes</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Berghella</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pajkrt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Espinoza</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mol</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Askie</surname>
                <given-names>L</given-names>
              </name>
              <collab>Preterm Premature Rupture of Membranes Meta-analysis (PPROMM) Collaboration</collab>
            </person-group>
            <article-title>Immediate Delivery Compared With Expectant Management in Late Preterm Prelabor Rupture of Membranes: An Individual Participant Data Meta-analysis.</article-title>
            <source>Obstet Gynecol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>131</volume>
            <issue>2</issue>
            <fpage>269</fpage>
            <page-range>269-279</page-range>
            <pub-id pub-id-type="pmid">29324621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shepherd</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Doyle</surname>
                <given-names>LW</given-names>
              </name>
              <name>
                <surname>Middleton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marret</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rouse</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Pryde</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Crowther</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2024</year>
            <month>May</month>
            <day>10</day>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>CD004661</fpage>
            <pub-id pub-id-type="pmid">38726883</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomson</surname>
                <given-names>AJ</given-names>
              </name>
              <collab>Royal College of Obstetricians and Gynaecologists</collab>
            </person-group>
            <article-title>Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24<sup>+0</sup> Weeks of Gestation: Green-top Guideline No. 73.</article-title>
            <source>BJOG</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>126</volume>
            <issue>9</issue>
            <fpage>e152</fpage>
            <page-range>e152-e166</page-range>
            <pub-id pub-id-type="pmid">31207667</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yudin</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>van Schalkwyk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van Eyk</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>[Not Available].</article-title>
            <source>J Obstet Gynaecol Can</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>39</volume>
            <issue>9</issue>
            <fpage>e213</fpage>
            <page-range>e213-e219</page-range>
            <pub-id pub-id-type="pmid">28859769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seaman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Kopkin</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Turrentine</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>226</volume>
            <issue>6</issue>
            <fpage>794</fpage>
            <page-range>794-801.e1</page-range>
            <pub-id pub-id-type="pmid">34973176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenyon</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Tarnow-Mordi</surname>
                <given-names>W</given-names>
              </name>
              <collab>ORACLE Collaborative Group</collab>
            </person-group>
            <article-title>Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group.</article-title>
            <source>Lancet</source>
            <year>2001</year>
            <month>Mar</month>
            <day>31</day>
            <volume>357</volume>
            <issue>9261</issue>
            <fpage>979</fpage>
            <page-range>979-88</page-range>
            <pub-id pub-id-type="pmid">11293640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenyon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boulvain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Neilson</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics for preterm rupture of membranes.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2013</year>
            <month>Dec</month>
            <day>02</day>
            <volume>2013</volume>
            <issue>12</issue>
            <fpage>CD001058</fpage>
            <pub-id pub-id-type="pmid">24297389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fox</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Gelber</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kalish</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Chasen</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>Contemporary practice patterns and beliefs regarding tocolysis among u.s. Maternal-fetal medicine specialists.</article-title>
            <source>Obstet Gynecol</source>
            <year>2008</year>
            <month>Jul</month>
            <volume>112</volume>
            <issue>1</issue>
            <fpage>42</fpage>
            <page-range>42-7</page-range>
            <pub-id pub-id-type="pmid">18591306</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raju</surname>
                <given-names>TNK</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Burchfield</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Joseph</surname>
                <given-names>GF</given-names>
              </name>
            </person-group>
            <article-title>Periviable birth: executive summary of a joint workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists.</article-title>
            <source>Obstet Gynecol</source>
            <year>2014</year>
            <month>May</month>
            <volume>123</volume>
            <issue>5</issue>
            <fpage>1083</fpage>
            <page-range>1083-1096</page-range>
            <pub-id pub-id-type="pmid">24785861</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Society for Maternal-Fetal Medicine (SMFM)</collab>
              <name>
                <surname>Battarbee</surname>
                <given-names>AN</given-names>
              </name>
              <name>
                <surname>Osmundson</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Louis</surname>
                <given-names>JM</given-names>
              </name>
              <collab>SMFM Publications Committee. Electronic address: pubs@smfm.org</collab>
            </person-group>
            <article-title>Society for Maternal-Fetal Medicine Consult Series #71: Management of previable and periviable preterm prelabor rupture of membranes.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2024</year>
            <month>Oct</month>
            <volume>231</volume>
            <issue>4</issue>
            <fpage>B2</fpage>
            <page-range>B2-B15</page-range>
            <pub-id pub-id-type="pmid">39025459</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrahami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Saucedo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rigouzzo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Deneux-Tharaux</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Azria</surname>
                <given-names>E</given-names>
              </name>
              <collab>ENCMM group</collab>
            </person-group>
            <article-title>Maternal mortality in women with pre-viable premature rupture of membranes: An analysis from the French confidential enquiry into maternal deaths.</article-title>
            <source>Acta Obstet Gynecol Scand</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>101</volume>
            <issue>12</issue>
            <fpage>1395</fpage>
            <page-range>1395-1402</page-range>
            <pub-id pub-id-type="pmid">36207816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simons</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>de Ruigh</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>van der Windt</surname>
                <given-names>LI</given-names>
              </name>
              <name>
                <surname>Kazemier</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>van Wassenaer-Leemhuis</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>van Teeffelen</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>van Leeuwen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mol</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>van 't Hooft</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pajkrt</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Maternal, perinatal and childhood outcomes of the PPROMEXIL-III cohort: Pregnancies complicated by previable prelabor rupture of membranes.</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>265</volume>
            <fpage>44</fpage>
            <page-range>44-53</page-range>
            <pub-id pub-id-type="pmid">34428686</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Kaufman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koelper</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Sonalkar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Roe</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Outcomes After Induction of Labor Compared With Dilation and Evacuation for the Management of Rupture of Membranes in the Second Trimester.</article-title>
            <source>Obstet Gynecol</source>
            <year>2024</year>
            <month>Apr</month>
            <day>01</day>
            <volume>143</volume>
            <issue>4</issue>
            <fpage>550</fpage>
            <page-range>550-553</page-range>
            <pub-id pub-id-type="pmid">38262065</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kishida</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Negishi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sagawa</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Fujimoto</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Spontaneous reseal of the fetal membranes in patients with high-leak PROM, confirmed by intra-amniotic injection of a dye (phenol-sulfonphthalein).</article-title>
            <source>Eur J Obstet Gynecol Reprod Biol</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>68</volume>
            <issue>1-2</issue>
            <fpage>219</fpage>
            <page-range>219-21</page-range>
            <pub-id pub-id-type="pmid">8886711</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hazan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ben-Arie</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Blickstein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hagay</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Reseal of ruptured membranes after genetic amniocentesis. A case report.</article-title>
            <source>J Reprod Med</source>
            <year>2000</year>
            <month>Oct</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>847</fpage>
            <page-range>847-9</page-range>
            <pub-id pub-id-type="pmid">11077637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Egerman</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Moorhead</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Cases with ruptured membranes that "reseal".</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>1990</year>
            <month>Sep</month>
            <volume>163</volume>
            <issue>3</issue>
            <fpage>1024</fpage>
            <page-range>1024-30; discussion 1030-2</page-range>
            <pub-id pub-id-type="pmid">2206055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Waters</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Mercer</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>The management of preterm premature rupture of the membranes near the limit of fetal viability.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>201</volume>
            <issue>3</issue>
            <fpage>230</fpage>
            <page-range>230-40</page-range>
            <pub-id pub-id-type="pmid">19733274</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kibel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Asztalos</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dunn</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Tward</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pittini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Melamed</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Outcomes of Pregnancies Complicated by Preterm Premature Rupture of Membranes Between 20 and 24 Weeks of Gestation.</article-title>
            <source>Obstet Gynecol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>128</volume>
            <issue>2</issue>
            <fpage>313</fpage>
            <page-range>313-320</page-range>
            <pub-id pub-id-type="pmid">27400016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27659.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffman</surname>
                <given-names>MK</given-names>
              </name>
            </person-group>
            <article-title>Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234.</article-title>
            <source>Obstet Gynecol</source>
            <year>2021</year>
            <month>Dec</month>
            <day>01</day>
            <volume>138</volume>
            <issue>6</issue>
            <fpage>945</fpage>
            <page-range>945-946</page-range>
            <pub-id pub-id-type="pmid">34794160</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
